Related Experiment Video

Updated: Jan 12, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K

Current status and unmet needs of pediatric HCV infection in Taiwan

Kai-Chi Chang1, Mei-Hwei Chang2

  • 1Department of Pediatrics, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan.

Journal of the Formosan Medical Association = Taiwan Yi Zhi
|November 4, 2025
PubMed

Insights

Hepatitis C virus (HCV) infection affects millions of children globally. Early diagnosis and treatment with direct-acting antivirals (DAAs) are crucial for managing pediatric HCV and preventing long-term liver disease.

Area of Science:

  • Hepatology
  • Pediatric Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection is a major global health issue, impacting 50 million people worldwide.
  • Pediatric HCV infection is under-addressed, with 3.5-5 million children chronically infected globally.
  • Taiwan's pediatric HCV prevalence is approximately 0.17%, with limited data on younger populations.

Purpose of the Study:

  • To highlight the significance of pediatric HCV infection in Taiwan.
  • To discuss transmission routes, health consequences, and treatment advancements in children.
  • To outline strategies for HCV elimination in Taiwan by 2030, focusing on pediatric populations.

Main Methods:

  • Analysis of nationwide data on pediatric HCV prevalence in Taiwan.
  • Review of current literature on HCV transmission, progression, and treatment in children.
  • Examination of challenges in pediatric HCV diagnosis and care.

Main Results:

  • Parenteral exposure, mother-to-infant transmission, and surgery are primary pediatric HCV routes.
  • Chronic pediatric HCV can lead to severe liver conditions like fibrosis, cirrhosis, and cancer.
  • Direct-acting antivirals (DAAs) show >95% efficacy and safety in children aged ≥3 years.

Conclusions:

  • Achieving HCV elimination in Taiwan necessitates enhanced pediatric-focused strategies.
  • Improving maternal screening and public awareness are vital for reducing transmission.
  • Timely diagnosis and treatment are essential for improving long-term outcomes in children with HCV.

Keywords:
Hepatitis C virusPediatrics

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.2K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.6K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
201
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
185
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
176
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.9K